Relx PLC (ADR)  

(Public, NYSE:RELX)   Watch this stock  
Find more results for NYSE:RUK
-0.20 (-0.91%)
Real-time:   11:08AM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 21.69 - 21.87
52 week 16.19 - 22.19
Open 21.82
Vol / Avg. 26,669.00/112,538.00
Mkt cap 43.60B
P/E 59.90
Div/yield     -/2.16
EPS 0.36
Shares 1.07B
Beta 0.80
Inst. own 4%
Jul 27, 2017
Half Year 2017 Relx PLC Earnings Presentation - 4:00AM EDT - Add to calendar
Jul 27, 2017
Half Year 2017 Relx PLC Earnings Release - 3:00AM EDT - Add to calendar
Jun 6, 2017
Relx PLC at Robert W Baird Global Consumer, Technology & Services Conference
May 23, 2017
Relx PLC at Berenberg European Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 16.74% 16.95%
Operating margin 23.23% 24.19%
EBITD margin - 33.66%
Return on average assets 9.57% 9.54%
Return on average equity 56.04% 52.02%
Employees 31,200 -
CDP Score - A


1-3 Strand
United Kingdom - Map
+44-20-71665500 (Phone)
+44-20-71665799 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


RELX PLC is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions. The Company's Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science and advance healthcare. The Risk & Business Analytics segment provides solutions and decision tools that combine public and industry-specific content with technology and analytics. The Legal segment is a provider of information and analytics to professionals in legal, corporate, government and non-profit organizations. Its Exhibitions segment consists of Reed Exhibitions, which is an exhibitions business, with events in over 30 countries.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 53
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 49
Bio & Compensation  - Reuters
Kumsal Bayazit Chairwoman, RELX Technology Forum and President, Exhibitions Europe
Bio & Compensation  - Reuters
Chet Burchett Chief Executive Officer - Exhibitions
Bio & Compensation  - Reuters
Youngsuk Chi Director of Corporate Affairs and Chairman Elsevier
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk & Business Analytics
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical & Medical
Age: 57
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Ian R. Fraser Human Resources Director
Bio & Compensation  - Reuters
Andrew Matuch Chief Strategy Officer
Bio & Compensation  - Reuters